通过柱切换技术与高效液相色谱联用的限进性柱对盐酸贝那普利的在线富集性能

以自制的限进性填料柱为预处理富集柱,Luna C₁₈柱为分析柱,通过柱切换技术将限进性填料柱与高效液相色谱联用(RAM-HPLC),研究了盐酸贝那普利的在线富集效果。考察了进样体积与峰面积、系统总压力的关系,以及常规进样与大体积进样的差别。当进样体积在100 μL以内时,峰面积随进样体积的增加而增加;当进样体积大于80 μL时,系统总压力变化明显。考虑对整个系统的保护,选择80 μL作为最大进样体积。同一浓度的样品进样20 μL与进样80 μL所得峰面积之间的线性关系良好。RAM柱对盐酸贝那普利具有良好的富集作用,能够有效提高HPLC的灵敏度,而且具有简单、经济的特点。     

疏水型色谱饼对人血清蛋白质组学样品的快速分离与制备

建立了疏水型色谱饼(10 mm×20 mm i.d.)与反相色谱(RPLC)离线二维色谱快速分离制备人血清蛋白质组学样品,并用基体辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)进行检测的方法。以4种标准蛋白质的稀溶液为模型进行分离富集,得到细胞色素c(Cyt-c)与肌红蛋白(Myo)的检出限均为1 pmol/μL,溶菌酶(Lys)和胰岛素（Ins）的检出限为0.1 pmol/μL。将此方法用于人血清蛋白质组学样品的分离与制备,随着血清处理量的增大,质谱可检出的组分数目与信号强度均增加,当血清处理量达到1.0 mL时,可检出低丰度蛋白质或多肽285个(相对分子质量均在15000以下)。研究中将1 μg Cyt-c加入到0.5 mL血清中,用上述方法在分离富集低丰度Cyt-c上取得了很好的效果。结果表明,采用疏水型色谱饼与反相色谱联用技术不仅可对血清样品中低丰度蛋白质进行有效的分离和富集,而且一次样品的处理量大,可显著提高低丰度蛋白质的分析、检测水平。     

色谱累加进样分离实验条件的研究

在采用反相液相色谱或亲和色谱完成蛋白质等大分子分离时,根据溶质保留值随溶剂梯度变化曲线上突变点的差别,可以通过累加进样分离法进行样品制备或直接柱内富集分析,但这一方法并非在任意条件下、对任何样品都适用。该文根据不同形式的保留值方程从理论上探讨了样品保留值与进样时间差、梯度洗脱速率等实验条件之间的关系;结果表明：两次进样的出峰时间差与进样时间间隔成正比关系,也与其在等度情况下的容量因子有关。样品中的两种组分在间隔进样时的流出时间差主要由两组分的容量因子决定,当样品中存在两种以上保留性能相近组分时,若保证指定的分离度,进样时间间隔存在一极大值,超出该范围,分离条件将不能满足     

大体积进样技术在环境分析中的应用

在毛细管气相色谱法(CGC)中,采用大体积进样技术(LVI),即使用能够容纳大体积样品的进样装置以及增加可控时间的溶剂蒸汽放空装置,可以满足环境样品中超痕量组分的分析要求,简化样品浓缩步骤以及实现液相色谱(LC)与CGC的在线联用。针对分析物的性质、毛细管柱的规格和分析的目的已发展了多种LVI。本文总结了几种常见的LVI,包括柱头进样(OCI)和程序升温进样(PTV),以及近年来发展的一些新技术,如在柱同时溶剂浓缩进样、样品直接引入进样/复杂基质进样和同时溶剂冷凝无分流进样,阐述了各种进样技术的基本原理及其与样品提取、LC纯化在线联用的方法在环境分析应用中的一些最新研究进展。     

在线富集毛细管液相色谱法分析脂溶性维生素和β-胡萝卜素

以硅胶基质ODS整体柱为分离柱, 建立了毛细管液相色谱-紫外/可见光度法测定脂溶性维生素和β-胡萝卜素的方法. 对流动相组成、流速、样品溶解液和进样体积等参数进行了系统优化, 采用溶剂梯度区带压缩效应作为在线富集技术来提高检测灵敏度. 与传统的进样方式相比, 采用溶剂梯度区带压缩在线富集技术时, 在不损失分辨率的前提下, 可通过增大进样体积将脂溶性维生素和β-胡萝卜素的检测灵敏度提高34～60倍. 方法可用于检测玉米中的痕量维生素E.     

10°锥角台锥型制备液相色谱柱的放大研究

将10° 锥角台锥型液相色谱柱放大至150 mm长、入口直径54 mm、出口直径27 mm,容积为200 mL,填料为粒径40～75 μm、孔径11 nm的C18球形硅胶。流动相在锥型柱内呈现塞子状流形。系统地评价了该柱的分离性能,结果表明: 在最佳流速为6 mL/min时,以萘峰计,锥型柱的折合理论塔板高度为2.11,柱效下降10%时的样品质量和体积载样量分别为2.1 mg和1.7 mL,与同长度同体积圆柱型柱相比,柱效提高了20%,质量载样量提高了16%以上,体积载样量提高了19%以上。当进样质量由2.4 mg增加到12 mg时,对羟基苯甲酸乙酯峰与对羟基苯甲酸丁酯峰的分离度(Rs2)由2.14降到1.71,对羟基苯甲酸丁酯峰与萘峰的分离度(Rs3)由2.91降到2.52;当进样体积由3 mL增加到19 mL,Rs2由2.23降到1.28,Rs3由2.95降到2.30,但此时的色谱峰峰形仍然高度对称,没有拖尾,有利于从基质中制备分离微量组分。实验结果表明锥型液相色谱柱将具有广泛的应用前景。     

10°锥角台锥型制备液相色谱柱的放大研究

将10°锥角台锥型液相色谱柱放大至150mm长、入口直径54mm、出口直径27mm,容积为200mL,填料为粒径40～75μm、孔径11nm的C18球形硅胶。流动相在锥型柱内呈现塞子状流形。系统地评价了该柱的分离性能,结果表明：在最佳流速为6mL/min时,以萘峰计,锥型柱的折合理论塔板高度为2.11,柱效下降10%时的样品质量和体积载样量分别为2.1mg和1.7mL,与同长度同体积圆柱型柱相比,柱效提高了20%,质量载样量提高了16%以上,体积载样量提高了19%以上。当进样质量由2.4mg增加到12mg时,对羟基苯甲酸乙酯峰与对羟基苯甲酸丁酯峰的分离度（Rs2）由2.14降到1.71,对羟基苯甲酸丁酯峰与萘峰的分离度（Rs3）由2.91降到2.52;当进样体积由3mL增加到19mL,Rs2由2.23降到1.28,Rs3由2.95降到2.30,但此时的色谱峰峰形仍然高度对称,没有拖尾,有利于从基质中制备分离微量组分。实验结果表明锥型液相色谱柱将具有广泛的应用前景。     

IEX/RP二维液相色谱中弱保留组分收集模式的构建及系统评价

以十通阀和捕集柱接口形式,构建了弱阴离子交换/反相(WAX/RP)二维液相色谱分离系统.通过将第一维离子交换色谱分析中的前部集中洗脱出的弱保留组分收集后单独分析,剩余样品进一步采用二维液相色谱分析,可以有效避免第二维色谱柱对特殊样品局部集中流出导致的第二维分离超柱容量问题,提高了系统的整体分离能力.使用4种蛋白胰蛋白酶酶解后的多肽样品评价该系统,在不分流的系统中共检测到115个峰.对第一维分离的前15 min分流后得到的组分单独分析,共识别出58个峰,后续的二维分离中共得到78个峰.2种方法相比,第二种方法检测峰数增加了21个,一些低丰度的组分在弱保留组分收集后被识别.     

微流量液相色谱在线大体积进样的方法和专用装置

本发明涉及微分离系统的进样方法,具体地说是一种微流量液相色谱在线大体积进样的方法和专用装置。在微流量液相色谱分离系统的流路中,添加多流路分流切换装置,使得系统在进样和分离时,流动相可以从不同流路分流。样品利用在固定相上的保留,实现色谱系统的大体积进样。     

大体积进样技术在气相色谱-质谱法测定 二英类化合物中的应用

利用大体积进样技术(large volume injection,LVI),结合气相色谱-质谱方法对二英的测定效果进行了研究。同时与传统分流/不分流进样技术进行了对比。对进样体积为1,5,10,25,50和100 μL的色谱图进行了分析。研究表明使用大体积进样方式,在不影响色谱分离度的同时,大幅度提高了分析灵敏度。通过对土壤样品的检测,证明该方法可以用于环境样品的实际测定。     

Sub-microlitre dialysis system to enable trace level peptide detection from volume-limited biological samples using MALDI-TOF-MS

The detection of peptides with mass spectrometry from volume-limited biological samples is a challenging task due to low sample volume, a broad range of peptide concentrations down to trace levels, endogenous high proteins and salt levels. Previously, a microspotting method was presented for trace-level peptide detection with MALDI-MS from sub-microlitre samples with biological salt levels. However, in the presence of proteins, peptide signals are significantly reduced. This paper presents a novel dialysis device for removal of proteins from sub-microlitre samples using a semipermeable hollow fiber membrane to enhance peptide detection. A dialysis device was constructed to perform sub-microlitre dialysis to remove proteins from complex samples. Angiotensin I was used as a model peptide in the presence of 350 mg L(-1) BSA prepared in physiological saline to mimic biological samples. In the absence of BSA, clear angiotensin I peaks were seen at 250 pM, yet in the presence of the BSA, 10 nM angiotensin I was barely detected. After dialysis, peak detection was improved to a 500 pM level. Protein removal and peptide recovery (approximately 66%) were determined using CE-LIF. Clinical vitreous samples as low as 200 nL were successfully dialyzed in 30 min and a 3-fold increase in peptide peaks were detected with greatly improved signals. This method is simple and can be a useful technique for trace level peptide detection from volume-limited biological samples.     

Determination of isophorone in food samples by solid-phase microextraction coupled with gas chromatography-mass spectrometry

A simple and sensitive method for the determination of isophorone in food samples was developed by headspace solid-phase microextraction (HS-SPME) coupled with gas chromatography-mass spectrometry (GC-MS). Isophorone was separated within 10 min by GC-MS using a DB-1 capillary column and detected with selective ion monitoring mode. The HS-SPME using a polydimethylsiloxane/divinylbenzene (PDMS/DVB) fiber provided effective sample enrichment, and was carried out by fiber exposition at 60 degrees C for 45 min. The extracted isophorone was easily desorbed by fiber exposition in the injection port of a capillary GC-MS system, and carryover was not observed. Using this method, the calibration curve of isophorone was linear in the range 20-1000 pg/mL, with a correlation coefficient 0.9996 (n = 18), and the detection limit (S/N = 3) was 0.5 pg/mL. The HS-SPME/GC-MS method showed 25,000-fold higher sensitivity than the direct injection method (1 microL injection). The within-day and between-day precisions (relative standard deviations) at the concentration of 1 ng/mL isophorone were 3.9% and 6.1% (n=5), respectively. This method was successfully applied to the analysis of food samples without interference peaks. The recoveries of isophorone spiked into food sample were above 84% for a 50 or 500 pg/mL spiking concentration. The analytical results of the contents of isophorone in various food samples were presented.     

Recent developments of nanoparticle-based enrichment methods for mass spectrometric analysis in proteomics

In proteome research, rapid and effective separation strategies are essential for successful protein identification due to the broad dynamic range of proteins in biological samples. Some important proteins are often expressed in ultra low abundance, thus making the pre-concentration procedure before mass spectrometric analysis prerequisite. The main purpose of enrichment is to isolate target molecules from complex mixtures to reduce sample complexity and facilitate the subsequent analyzing steps. The introd...     

Evaluation of the Effects of Sample Dilution and Volume in Hydrophilic Interaction Liquid Chromatography

The effects of sample dilution and volume on the peak shapes in hydrophilic interaction liquid chromatography (HILIC) were evaluated using fluorescence-labeled thiols as model compounds and ZIC-HILIC as the HILIC column. The content of acetonitrile, which was selected as the diluent of the aqueous samples in this study, was varied 0?95 % in the injection samples, and the numbers of theoretical plates (NTPs) and retention times were compared using a mobile phase composed of ammonium formate buffer/acetonitrile (25:75, v/v). Although the NTPs and retention times decreased with decreasing acetonitrile content, the peak shapes were acceptable for samples with acetonitrile contents down to 50 % based on asymmetry factor. Furthermore, the sample volume had a serious effect for samples with low acetonitrile contents. Although a high content of acetonitrile in samples is still recommended, the capacity for the aqueous solution in the injection samples under HILIC conditions should vary with the composition of the mobile phase and may be larger than previously thought. These findings should be helpful in deciding the sample composition under HILIC conditions, particularly in bioanalysis, where aqueous solution is often contained in the injection samples and the sample dilution with an organic solvent may decrease the detection sensitivity.     

Evaluation of the Effects of Sample Dilution and Volume in Hydrophilic Interaction Liquid Chromatography

The effects of sample dilution and volume on the peak shapes in hydrophilic interaction liquid chromatography (HILIC) were evaluated using fluorescence-labeled thiols as model compounds and ZIC-HILIC as the HILIC column. The content of acetonitrile, which was selected as the diluent of the aqueous samples in this study, was varied 0−95 % in the injection samples, and the numbers of theoretical plates (NTPs) and retention times were compared using a mobile phase composed of ammonium formate buffer/acetonitrile (25:75, v/v). Although the NTPs and retention times decreased with decreasing acetonitrile content, the peak shapes were acceptable for samples with acetonitrile contents down to 50 % based on asymmetry factor. Furthermore, the sample volume had a serious effect for samples with low acetonitrile contents. Although a high content of acetonitrile in samples is still recommended, the capacity for the aqueous solution in the injection samples under HILIC conditions should vary with the composition of the mobile phase and may be larger than previously thought. These findings should be helpful in deciding the sample composition under HILIC conditions, particularly in bioanalysis, where aqueous solution is often contained in the injection samples and the sample dilution with an organic solvent may decrease the detection sensitivity.

     

Rapid affinity purification of erythropoietin from biological samples using disposable monoliths

Identification of post-translational modifications of proteins in biological samples often requires access to preanalytical purification and concentration methods. In the purification step high or low molecular weight substances can be removed by size exclusion filters, and high abundant proteins can be removed, or low abundant proteins can be enriched, by specific capturing tools. In this paper is described the experience and results obtained with a recently emerged and easy-to-use affinity purification kit for enrichment of the low amounts of EPO found in urine and plasma specimens. The kit can be used as a pre-step in the EPO doping control procedure, as an alternative to the commonly used ultrafiltration, for detecting aberrantly glycosylated isoforms. The commercially available affinity purification kit contains small disposable anti-EPO monolith columns (6 μL volume, Ø7 mm, length 0.15 mm) together with all required buffers. A 24-channel vacuum manifold was used for simultaneous processing of samples. The column concentrated EPO from 20 mL urine down to 55 μL eluate with a concentration factor of 240 times, while roughly 99.7% of non-relevant urine proteins were removed. The recoveries of Neorecormon (epoetin beta), and the EPO analogues Aranesp and Mircera applied to buffer were high, 76%, 67% and 57%, respectively. The recovery of endogenous EPO from human urine was 65%. High recoveries were also obtained when purifying human, mouse and equine EPO from serum, and human EPO from cerebrospinal fluid. Evaluation with the accredited EPO doping control method based on isoelectric focusing (IEF) showed that the affinity purification procedure did not change the isoform distribution for rhEPO, Aranesp, Mircera or endogenous EPO. The kit should be particularly useful for applications in which it is essential to avoid carry-over effects, a problem commonly encountered with conventional particle-based affinity columns. The encouraging results with EPO propose that similar affinity monoliths, with the appropriate antibodies, should constitute useful tools for general applications in sample preparation, not only for doping control of EPO and other hormones such as growth hormone and insulin but also for the study of post-translational modifications of other low abundance proteins in biological and clinical research, and for sample preparation prior to in vitro diagnostics.     

Using enrichment index for quality control of secretory protein sample and identification of secretory proteins

Analysis of secretory proteins is an important area in proteomic research. We propose that a good secretory protein sample should be enriched with known secretory proteins, and a secretory protein should be enriched in the secretory protein sample compared with its corresponding soluble cell lysate. Positive identifications of proteins were subjected to quantitation of spectral counts, which reflect relative protein abundance. Enrichment index of the sample (EIS) and the enrichment index for protein (EIP) were obtained by comparing proteins identified in the secretory protein sample and those in the soluble cell lysate sample. The quality of the secretory protein sample can be represented by EIS. EIP was used to identify the secretory proteins. The secretory proteins from mouse dendritic cell sarcoma (DCS) were analyzed by MS. The EISs of two samples were 75.4 and 84.65, respectively. 72 proteins were significantly enriched in secretory protein samples, of which 42 proteins were either annotated in Swiss‐Prot and/or predicted by signal peptides to be secretory. In the remaining 30 proteins, 12 and 15 proteins were positively predicted by SecretomeP and ProP, respectively, and 5 proteins were positive by both methods. Furthermore, 11 proteins were found to be present in exosome in other studies that involved mice dendritic cell lines. We suggest that this assessment method is helpful for systemic research of secretory proteins and biomarker discovery for diseases such as cancer. Copyright © 2008 John Wiley & Sons, Ltd.     

Large Volume Injection of Biological Samples Dissolved in a Non-Eluting Solvent: A Way to Increase Sensitivity and a Means of Automating Drug Determination Using Hplc

Abstract

The injected volume of a sample dissolved in the mobile phase of an HPLC system must be maintained as small as possible so as to minimize the loss in efficiency. Generally this requirement limits the sensitivity of HPLC methods devoted to trace quantity determinations of drugs in biological fluids. In order to avoid this limitation and to increase the effective sensitivity of HPLC methods for determination of drugs such as antrafenine, nifuroxazide and cipropride, the samples were dissolved in a non-eluting solvent and a large volume (> 100 μl) was injected on to the chromatographic column.

The above-mentioned compounds and their internal standards were dissolved in a series of eluting and non-eluting solvents and increasing volumes (5 to 1000 μl) were injected. Peaks corresponding to injections made in an eluting solvent showed retention times independent of the injection volume but their variances increased with the volume injected. In contrast, peaks corresponding to injections made in a non-eluting solvent, similar to the mobile phase, had a variance independent of the injection volume but their retention times increased linearly with the injection volume. The repeated injection of such non-eluting solvents had no influence on chromatographic behaviour. Peaks corresponding to compounds injected in a non-eluting solvent made with components different from those of the mobile phase had a variance independent of the injection volume but their retention times varied both with the injection volume and with the interval between injection.

The application of non-eluting solvents has been defined theoretically and it has been demonstrated that solutions composed of 25% of the mobile phase diluted with the least eluting of its components act as non-eluting solvents and can be injected in large volume without loss in efficiency. This feature could be used to inject all the samples volume or only part of it, manually or automatically, since any automatic injector can be used with large volumes.

Thus, using the relatively simple procedure of making injections with a non-eluting solvent it is possible to increase both sensitivity and the rate of sample analysis.     

水溶性硼酸亲和富集材料的制备及基于酶联免疫吸附法检测人肝微粒体糖蛋白的应用

生物样品中的糖蛋白丰度低,且在检测中易受到其它非糖蛋白的抑制和干扰,需在分析检测前对糖蛋白进行富集,但常规的基于固相材料的糖蛋白富集方法不易与生物技术中最经典的酶联免疫吸附法(ELISA)兼容.本研究以树枝状聚合物PAMAM 4.0为载体, 结合硼酸亲和技术,制备了新型水溶性硼酸亲和富集材料(DBC),并将其应用于基于ELISA的人肝微粒体中糖蛋白的检测.采用标准糖蛋白对DBC富集条件进行优化,然后考察其灵敏度和抗干扰能力,将优化后的方法应用于复杂样品人肝微粒体糖蛋白富集.结果表明,DBC对糖蛋白的富集选择性可高达100000倍,可将糖蛋白的富集信号提高100倍.以DBC为富集材料,与ELISA分析技术相结合,只需一步简单的孵育,即可实现生物样品中糖蛋白的高灵敏度、高选择性检测,为疾病相关的糖蛋白组学研究提供了一种有效的检测手段.